Curiox Biosystems Cash Flow Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-27,177	-8,089	-10,040	-11,495	-14,524
Depreciation & Amortization	2,873	2,578	1,952	1,598	1,236
Loss (Gain) From Sale of Assets	68.44	123.27	-13.02	12.11	-
Asset Writedown & Restructuring Costs	423.21	-	-	-	84.1
Stock-Based Compensation	992.87	777.17	-8.84	678.35	613.76
Provision & Write-off of Bad Debts	25.72	2.14	17.29	1.88	12.66
Other Operating Activities	14,551	-5,163	-334.89	301.64	7,214
Change in Accounts Receivable	-1,436	2,737	227.68	1,212	75.22
Change in Inventory	-1,482	-458.81	195.89	-829.5	-1,163
Change in Accounts Payable	157.28	-1,196	-688.69	-1,509	809.8
Change in Other Net Operating Assets	-107.24	-1,009	528.91	140.75	516.07
Operating Cash Flow	-11,109	-9,698	-8,164	-9,888	-5,126
Capital Expenditures	-136.1	-257.88	-211.53	-822.86	-261.26
Sale of Property, Plant & Equipment	-	-	1.79	-	-
Sale (Purchase) of Intangibles	-	-	-	-17.9	-
Investment in Securities	1,000	-4,000	3,125	5,691	-8,007
Other Investing Activities	55.87	-16.81	-16.69	-116.92	-43.25
Investing Cash Flow	919.77	-4,275	2,898	4,734	-8,311
Long-Term Debt Issued	-	19,998	-	-	-
Long-Term Debt Repaid	-412.19	-397.16	-320.22	-236.66	-93.69
Net Debt Issued (Repaid)	-412.19	19,600	-320.22	-236.66	-93.69
Issuance of Common Stock	806.96	260.9	17,964	-	-
Other Financing Activities	-	0	-0	-	13,087
Financing Cash Flow	394.77	19,861	17,644	-236.66	16,999
Foreign Exchange Rate Adjustments	392.46	390.05	-65.54	-15.47	397.85
Miscellaneous Cash Flow Adjustments	-	-0	-	-	-
Net Cash Flow	-9,402	6,279	12,312	-5,407	3,960
Free Cash Flow	-11,245	-9,956	-8,376	-10,711	-5,387
Free Cash Flow Margin	-218.29%	-217.02%	-123.39%	-148.00%	-97.54%
Free Cash Flow Per Share	-680.67	-619.10	-585.95	-1509.32	-413.36
Cash Interest Paid	22.74	34.68	25.7	29.23	9.35
Cash Income Tax Paid	11.92	50.11	11.81	16.14	-3.84
Levered Free Cash Flow	-14,077	3,490	-3,723	-8,886	-4,602
Unlevered Free Cash Flow	-13,334	3,929	-3,707	-7,150	-3,537
Change in Working Capital	-2,867	72.97	263.79	-985.77	238.26

Source: S&P Global Market Intelligence. Standard template. Financial Sources.